Profile of Pulmonary Tuberculosis Patients in Dr. Soetomo General Academic Hospital
DOI:
https://doi.org/10.24293/ijcpml.v29i3.2040Keywords:
Tuberculosis, lung disease, Dr. Soetomo General Academic HospitalAbstract
Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis, which mainly attacks the lungs but can also infect other body organs. Tuberculosis is a global health problem that causes the highest death after Human Immunodeficiency Virus (HIV). Indonesia ranks third highest in the world, with 420,994 cases in 2017. This study aims to determine the profile of pulmonary tuberculosis patients at Dr. Soetomo General Academic Hospital, Surabaya from January 1st to December 31st, 2019. The research was conducted using a descriptive method by collecting secondary data, through medical records of pulmonary tuberculosis patients at the Inpatient Unit of Dr. Soetomo General Academic Hospital during January 1st - December 31st, 2019. The data obtained were processed according to gender, age, education, occupation, comorbidities, clinical symptoms, history of TB treatment, sputum examination results, and GeneXpert. This study uses total sampling presented in the form of pictures. The results showed that most of the patients were male (61.92%), aged 45-54 years old (25.13%), high school education level (56.48%), and private employees (34.45%). The most common comorbidities were diabetes mellitus (35.07%), the most clinical symptoms found were shortness of breath (29.56%), the complete history of TB treatment was first-line OAT (42.22%), as many as (77.97%) sputum examinations showed no data. Many (7.77%) GeneXpert results showed resistance to rifampicin after six months of therapy.
Downloads
References
Soetrisno ARP, Setiabudi RJ, Wulandari L. Profile of pulmonary tuberculosis patients with type 2 diabetes mellitus in pulmonary Department Dr. Soetomo General Hospital Surabaya. Jurnal Respirasi, 2020; 6(2): 35–39.
Septiawan M, Desnita R. Profil penderita penyakit tuberkulosis paru BTA positif di UPT pelayanan penyakit paru Pontianak periode Januari 2017 sampai September 2018. Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN, [online]. 2019; 4(1): 1-6. Available from: <https://jurnal.untan.ac.id/index.php/jmfarmasi/article/view/41659> (accessed May 15, 2022).
Kementerian Kesehatan Republik Indonesia. Pedoman nasional pelayanan kedokteran tata laksana tuberkulosis. Jakarta, 2019; 39-46.
Matheos S, Marhana IA, Rahaju, AS. Hubungan antara hasil pemeriksaan GenXpert cairan pleura dengan histopatologi biopsi pleura pada pasien efusi pleura tuberkulosis. Jurnal Respirasi, 2018; 38(1): 1–6.
Kementerian Kesehatan Republik Indonesia. Petunjuk teknis pemeriksaan TB menggunakan tes cepat molekuler. Jakarta, 2017; 4-7.
Priyanka S, Madhur V, Meenakshi B, Himanshu S, Neelam R, Anita V, Geeta P. Epidemiological profile of tuberculosis patients in Delhi, India. Journal of Family Medicine and Primary Care, [online] 2019; 8(10): 3388-3392. Available at: <https://journals.lww.com/jfmpc/Fulltext/2019/08100/Epidemiological_profile_of_tuberculosis_patients.53.aspx> (accessed May 10, 2022).
Elisya Y, Kurniawan A, Yusuf F. Profil pengobatan tuberkulosis paru pada pasien rawat inap dengan status riwayat COVID-19 di Rumah Sakit Umum Daerah Pasar Minggu. Teknologi dan Seni Kesehatan, [online]. 2021; 12(2): 172-185. Available from: https://sanitas.ejournal.id/index.php/SANITAS/article/view/20211201-elisya/20211201-172-185 (accessed May 10, 2022).
Dong Z, Qi-Qi Wang, Yu SC, Huang F, Liu JJ, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006-2020. Infections Diseases of Poverty, 2022; 11: 1.
Dian, Ningsih P. Perbedaan karakteristik pasien TB paru dengan dan tanpa efusi pleura di bangsal paru RSUP Dr. M. Djamil Padang periode 1 Januari 2017 – 31 Desember 2018. R Medicine, 2020; 1–55.
Novalisa, Ressi S, Nurmainah. Analisis faktor-faktor yang mempengaruhi kepatuhan penggunaan obat tuberkulosis pada pasien di puskesmas. Journal Syifa Sciences and Clinical Research (JSSCR), 2022; 4(2): 342-353.
Nautiyal GR, Mittal S, Awasthi S, Singh RK. Knowledge about tuberculosis among pulmonary tuberculosis patients: A cross-sectional study from Uttarakhand. Journal of Family Medicine and Primary Care, 2019; 8(5): 1735-1740.
Maelani T, Cahyati WH. Karakteristik penderita, efek samping obat dan putus berobat tuberkulosis paru. Higeia Journal of Public Health Research and Development, 2019; 3(4): pp. 625-634. Available from: https://journal.unnes.ac.id/sju/index.php/higeia/article/view/31852 (accessed May 10, 2022).
Rosdiana D. Tuberkulosis paru resisten obat dengan komorbiditas diabetes melitus. Jurnal Kesehatan Melayu, 2017; 1(1): 45-50.
Adigun R, Singh R. Tuberculosis. StatPearls. 2022; 1-22. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441916/ (Accessed May 19, 2021).
Bakhtiar M, Wiedyaningsih C, Munif Yasin N, Ari Kristina S. Hubungan karakteristik, kepatuhan, dan outcome klinis pasien tuberkulosis paru di puskesmas Kabupaten Bantul. Majalah Farmaseutik, 2020; 17(2): 256-269.
Robiah, Anisatur. Pola peresepan Obat Anti Tuberkulosis (OAT) di Balai Kesehatan Masyarakat (BALKESMAS) Klaten. Repositery Universitas Muhammadiyah Klaten, 2017; 6-7.
Soedarsono S, Jayanti RP, Mertaniasih NM, Kusmiati T, Permatasari A, et al. Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis. International Journal of Infectious Disease, 2022; 117: 8–14.
Sofiyatun V. Implementasi program penanggulangan tuberculosis paru. Higeia Journal of Public Health Research and Development, 2019; 3(1): 74–86. Available from: https://journal.unnes.ac.id/sju/index.php/higeia/article/view/24952 (accessed May 19, 2021).
Irmawati I, Danuri A, Sudiyono S, Rahmawati F. Analisis kuantitatif rekam medis pasien rawat inap di Bangsal Mawar RSUD Ungaran. J Rekam Medis dan Inf Kesehat, 2018; 10: 1.
Kementerian Kesehatan Republik Indonesia. Penderita tuberkulosis terbanyak dari usia produktif pada 2020. Jakarta, 2021; 1-2.
Arega B, Menbere F, Getachew Y. Prevalence of rifampicin-resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis, 2019; 19(1): 1-5.
Wasihun A, Hailu G, Dejene, T. Prevalence of Mycobacterium tuberculosis (rifampicin-resistant MTB) and associated risk actors among pulmonary presumptive TB patients in Eastern Amhara, Ethiopia: 2015–2019. Infectious Diseases and Therapy, 2021; 10(3): 1299-1308.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
